ID   H4_RAT                  Reviewed;         103 AA.
AC   P62804; P02304; P02305; Q5BM23; Q7M0E8;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 179.
DE   RecName: Full=Histone H4;
DE   Contains:
DE     RecName: Full=Osteogenic growth peptide;
DE              Short=OGP;
GN   Name=H4c2; Synonyms=Hist1h4b, Hist4;
GN   and
GN   Name=Hist1h4m;
GN   and
GN   Name=H4c16; Synonyms=H4f16, H4ft, Hist4h4 {ECO:0000312|RGD:620814};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=3691674; DOI=10.1016/0014-4827(87)90293-x;
RA   Grimes S., Weisz-Carrington P., Daum H. III, Smith J., Green L., Wright K.,
RA   Stein G., Stein J.;
RT   "A rat histone H4 gene closely associated with the testis-specific H1t
RT   gene.";
RL   Exp. Cell Res. 173:534-545(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2920170; DOI=10.1016/0167-4781(89)90032-8;
RA   Wolfe S.A., Anderson J.V., Grimes S.R., Stein G.S., Stein J.S.;
RT   "Comparison of the structural organization and expression of germinal and
RT   somatic rat histone H4 genes.";
RL   Biochim. Biophys. Acta 1007:140-150(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1706721; DOI=10.1016/s0021-9258(18)38164-x;
RA   Wolfe S.A., Grimes S.R.;
RT   "Protein-DNA interactions within the rat histone H4t promoter.";
RL   J. Biol. Chem. 266:6637-6643(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spleen;
RX   PubMed=16042990; DOI=10.1016/j.peptides.2005.03.013;
RA   Poirier R., Lemaire I., Dumont M., Leduc N., Le H.T., Lemaire S.;
RT   "Correlation between the expression of the histone H4 mRNA variant H4-v.1
RT   and the levels of histone H4-(86-100) and H4-(89-102) (OGP) in various rat
RT   tissues and alveolar macrophages.";
RL   Peptides 26:1503-1511(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-103, ACETYLATION AT SER-2 AND LYS-17, AND METHYLATION
RP   AT LYS-21.
RX   PubMed=5171427; DOI=10.1016/s0300-9084(71)80165-7;
RA   Sautiere P., Tyrou D., Moschetto Y., Biserte G.;
RT   "Primary structure of glycine-rich and arginine-rich histone isolated from
RT   chloroleukemic tumor of the rat.";
RL   Biochimie 53:479-483(1971).
RN   [7]
RP   PROTEIN SEQUENCE OF 5-14 AND 19-32.
RC   TISSUE=Liver;
RX   PubMed=7932740; DOI=10.1006/jmbi.1994.1629;
RA   Baneres J.L., Essalouh L., Jariel-Encontre I., Mesnier D., Garrod S.,
RA   Parello J.;
RT   "Evidence indicating proximity in the nucleosome between the histone H4 N
RT   termini and the globular domain of histone H1.";
RL   J. Mol. Biol. 243:48-59(1994).
RN   [8]
RP   PROTEIN SEQUENCE OF 61-78, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 90-103, AND SUBCELLULAR LOCATION.
RX   PubMed=1582415; DOI=10.1002/j.1460-2075.1992.tb05238.x;
RA   Bab I., Gazit D., Chorev M., Muhlrad A., Shteyer A., Greenberg Z.,
RA   Namdar M., Kahn A.;
RT   "Histone H4-related osteogenic growth peptide (OGP): a novel circulating
RT   stimulator of osteoblastic activity.";
RL   EMBO J. 11:1867-1873(1992).
RN   [10]
RP   ALTERNATIVE INITIATION.
RX   PubMed=10318873; DOI=10.1074/jbc.274.20.14474;
RA   Bab I., Smith E., Gavish H., Attar-Namdar M., Chorev M., Chen Y.C.,
RA   Muhlrad A., Birnbaum M.J., Stein G., Frenkel B.;
RT   "Biosynthesis of osteogenic growth peptide via alternative translational
RT   initiation at AUG85 of histone H4 mRNA.";
RL   J. Biol. Chem. 274:14474-14481(1999).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19343714; DOI=10.1002/pmic.200800558;
RA   Pramod K.S., Bharat K., Sanjay G.;
RT   "Mass spectrometry-compatible silver staining of histones resolved on
RT   acetic acid-urea-Triton PAGE.";
RL   Proteomics 9:2589-2592(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-81 AND TYR-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: [Histone H4]: Core component of nucleosome. Nucleosomes wrap
CC       and compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones thereby
CC       play a central role in transcription regulation, DNA repair, DNA
CC       replication and chromosomal stability. DNA accessibility is regulated
CC       via a complex set of post-translational modifications of histones, also
CC       called histone code, and nucleosome remodeling.
CC   -!- FUNCTION: [Osteogenic growth peptide]: Stimulates osteogenesis and
CC       hematopoiesis. {ECO:0000269|PubMed:1582415}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA
CC       (By similarity). Found in a co-chaperone complex with DNJC9, MCM2 and
CC       histone H3.3-H4 dimers (By similarity). Within the complex, interacts
CC       with DNJC9 (via C-terminus); the interaction is direct (By similarity).
CC       Interacts with NASP; NASP is a histone chaperone that stabilizes and
CC       maintains a soluble pool of Histone H3-H4 dimers (By similarity).
CC       {ECO:0000250|UniProtKB:P62805, ECO:0000250|UniProtKB:P62806}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1582415}. Chromosome
CC       {ECO:0000269|PubMed:1582415}.
CC   -!- SUBCELLULAR LOCATION: [Osteogenic growth peptide]: Secreted
CC       {ECO:0000269|PubMed:1582415}. Note=Osteogenic growth peptide is
CC       secreted by a mechanism independent from a hydrophobic signal sequence.
CC       The mature peptide may be imported into secretory lysosomes by an
CC       ABCA1-related protein. {ECO:0000269|PubMed:1582415}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Histone H4;
CC         IsoId=P62804-1; Sequence=Displayed;
CC       Name=OGP precursor;
CC         IsoId=P62804-2; Sequence=VSP_018804;
CC   -!- TISSUE SPECIFICITY: OGP is found in serum. A potentially OGP-specific
CC       transcript is highly expressed in spleen with lower levels in lung,
CC       liver, thymus, spinal chord, pituitary gland, adrenal gland, bone
CC       marrow and lymph nodes as well as very low levels in kidney, heart and
CC       brain. {ECO:0000269|PubMed:16042990}.
CC   -!- PTM: Acetylation at Lys-6 (H4K5ac), Lys-9 (H4K8ac), Lys-13 (H4K12ac)
CC       and Lys-17 (H4K16ac) occurs in coding regions of the genome but not in
CC       heterochromatin. {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Citrullination at Arg-4 (H4R3ci) by PADI4 impairs methylation.
CC       {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Monomethylation and asymmetric dimethylation at Arg-4 (H4R3me1 and
CC       H4R3me2a, respectively) by PRMT1 favors acetylation at Lys-9 (H4K8ac)
CC       and Lys-13 (H4K12ac). Demethylation is performed by JMJD6. Symmetric
CC       dimethylation on Arg-4 (H4R3me2s) by the PRDM1/PRMT5 complex may play a
CC       crucial role in the germ-cell lineage (By similarity).
CC       {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Monomethylated, dimethylated or trimethylated at Lys-21 (H4K20me1,
CC       H4K20me2, H4K20me3). Monomethylation is performed by KMT5A/SET8.
CC       Trimethylation is performed by KMT5B and KMT5C and induces gene
CC       silencing. Monomethylated at Lys-13 (H4K12me1) by N6AMT1; H4K12me1
CC       modification is present at the promoters of numerous genes encoding
CC       cell cycle regulators. {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Acetyl-methylated at Lys-6 and Lys-13 (H4K5acme and H4K12acme,
CC       respectively), acetyl-methylation is an epigenetic mark of active
CC       chromatin associated with increased transcriptional initiation. Acetyl-
CC       methylation is formed by acetylation by EP300/p300 of lysine residues
CC       that are already monomethylated on the same side chain. H4K5acme and
CC       H4K12acme marks specifically bind BRD2. {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Phosphorylated by PAK2 at Ser-48 (H4S47ph). This phosphorylation
CC       increases the association of H3.3-H4 with the histone chaperone HIRA,
CC       thus promoting nucleosome assembly of H3.3-H4 and inhibiting nucleosome
CC       assembly of H3.1-H4 (By similarity). {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Ubiquitinated by the CUL4-DDB-RBX1 complex in response to
CC       ultraviolet irradiation. This may weaken the interaction between
CC       histones and DNA and facilitate DNA accessibility to repair proteins.
CC       Monoubiquitinated at Lys-92 of histone H4 (H4K91ub1) in response to DNA
CC       damage. The exact role of H4K91ub1 in DNA damage response is still
CC       unclear but it may function as a licensing signal for additional
CC       histone H4 post-translational modifications such as H4 Lys-21
CC       methylation (H4K20me) (By similarity). {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Sumoylated, which is associated with transcriptional repression.
CC       {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes (By similarity).
CC       {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. {ECO:0000250|UniProtKB:P62806}.
CC   -!- PTM: Glutarylation at Lys-92 (H4K91glu) destabilizes nucleosomes by
CC       promoting dissociation of the H2A-H2B dimers from nucleosomes.
CC       {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Ufmylated; monofmylated by UFL1 at Lys-32 (H4K31Ufm1) in response
CC       to DNA damage. {ECO:0000250|UniProtKB:P62805}.
CC   -!- PTM: Lactylated in macrophages by EP300/P300 by using lactoyl-CoA
CC       directly derived from endogenous or exogenous lactate, leading to
CC       stimulates gene transcription. {ECO:0000250|UniProtKB:P62805}.
CC   -!- SIMILARITY: Belongs to the histone H4 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27433; AAA60735.1; -; Genomic_DNA.
DR   EMBL; X13554; CAA31906.1; -; Genomic_DNA.
DR   EMBL; M28409; AAA41306.1; -; Genomic_DNA.
DR   EMBL; AY936209; AAX28930.1; -; mRNA.
DR   EMBL; BC100619; AAI00620.1; -; mRNA.
DR   PIR; A91265; HSRT4.
DR   PIR; S53749; S53749.
DR   RefSeq; NP_001116941.1; NM_001123469.1. [P62804-1]
DR   RefSeq; NP_001258150.1; NM_001271221.1. [P62804-1]
DR   RefSeq; NP_073177.1; NM_022686.2. [P62804-1]
DR   RefSeq; XP_003749904.3; XM_003749856.4.
DR   RefSeq; XP_008761668.1; XM_008763446.1.
DR   RefSeq; XP_008761670.1; XM_008763448.2.
DR   RefSeq; XP_008769992.1; XM_008771770.2.
DR   RefSeq; XP_008772221.1; XM_008773999.1.
DR   RefSeq; XP_578415.4; XM_578415.6.
DR   AlphaFoldDB; P62804; -.
DR   SMR; P62804; -.
DR   BioGRID; 1200084; 1.
DR   BioGRID; 249165; 7.
DR   BioGRID; 253434; 2.
DR   BioGRID; 254947; 2.
DR   BioGRID; 595036; 2.
DR   IntAct; P62804; 4.
DR   MINT; P62804; -.
DR   STRING; 10116.ENSRNOP00000039602; -.
DR   GlyGen; P62804; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P62804; -.
DR   PhosphoSitePlus; P62804; -.
DR   SwissPalm; P62804; -.
DR   jPOST; P62804; -.
DR   PaxDb; 10116-ENSRNOP00000039602; -.
DR   ABCD; P62804; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000040210.5; ENSRNOP00000039602.3; ENSRNOG00000032224.5. [P62804-1]
DR   Ensembl; ENSRNOT00000080490.2; ENSRNOP00000071163.1; ENSRNOG00000054017.2. [P62804-1]
DR   Ensembl; ENSRNOT00000088408.2; ENSRNOP00000074659.1; ENSRNOG00000063552.1. [P62804-1]
DR   Ensembl; ENSRNOT00000105806.1; ENSRNOP00000093704.1; ENSRNOG00000065263.1. [P62804-1]
DR   Ensembl; ENSRNOT00000106060.1; ENSRNOP00000091116.1; ENSRNOG00000065263.1. [P62804-1]
DR   Ensembl; ENSRNOT00000107328.1; ENSRNOP00000087795.1; ENSRNOG00000070513.1. [P62804-1]
DR   Ensembl; ENSRNOT00000112120.1; ENSRNOP00000079614.1; ENSRNOG00000066473.1. [P62804-1]
DR   Ensembl; ENSRNOT00000112947.1; ENSRNOP00000091037.1; ENSRNOG00000064025.1. [P62804-1]
DR   Ensembl; ENSRNOT00000114507.1; ENSRNOP00000080829.1; ENSRNOG00000070706.1. [P62804-1]
DR   Ensembl; ENSRNOT00000115294.1; ENSRNOP00000087751.1; ENSRNOG00000067648.1. [P62804-1]
DR   Ensembl; ENSRNOT00000117583.1; ENSRNOP00000080971.1; ENSRNOG00000065263.1. [P62804-1]
DR   Ensembl; ENSRNOT00000120238.1; ENSRNOP00000091524.1; ENSRNOG00000066473.1. [P62804-1]
DR   Ensembl; ENSRNOT00055008443; ENSRNOP00055006392; ENSRNOG00055005264. [P62804-1]
DR   Ensembl; ENSRNOT00055008813; ENSRNOP00055006703; ENSRNOG00055005480. [P62804-1]
DR   Ensembl; ENSRNOT00055008816; ENSRNOP00055006706; ENSRNOG00055005484. [P62804-1]
DR   Ensembl; ENSRNOT00055008824; ENSRNOP00055006714; ENSRNOG00055005492. [P62804-1]
DR   Ensembl; ENSRNOT00055008834; ENSRNOP00055006724; ENSRNOG00055005500. [P62804-1]
DR   Ensembl; ENSRNOT00055046044; ENSRNOP00055037771; ENSRNOG00055026675. [P62804-1]
DR   Ensembl; ENSRNOT00055046060; ENSRNOP00055037787; ENSRNOG00055026687. [P62804-1]
DR   Ensembl; ENSRNOT00055056961; ENSRNOP00055047057; ENSRNOG00055032934. [P62804-1]
DR   Ensembl; ENSRNOT00060016012; ENSRNOP00060012527; ENSRNOG00060009485. [P62804-1]
DR   Ensembl; ENSRNOT00060016023; ENSRNOP00060012537; ENSRNOG00060009491. [P62804-1]
DR   Ensembl; ENSRNOT00060024023; ENSRNOP00060019142; ENSRNOG00060014042. [P62804-1]
DR   Ensembl; ENSRNOT00060024561; ENSRNOP00060019590; ENSRNOG00060014373. [P62804-1]
DR   Ensembl; ENSRNOT00060025863; ENSRNOP00060020683; ENSRNOG00060015093. [P62804-1]
DR   Ensembl; ENSRNOT00060025920; ENSRNOP00060020735; ENSRNOG00060015121. [P62804-1]
DR   Ensembl; ENSRNOT00060025973; ENSRNOP00060020786; ENSRNOG00060015156. [P62804-1]
DR   Ensembl; ENSRNOT00060026053; ENSRNOP00060020860; ENSRNOG00060015197. [P62804-1]
DR   Ensembl; ENSRNOT00065019583; ENSRNOP00065015014; ENSRNOG00065012047. [P62804-1]
DR   Ensembl; ENSRNOT00065019590; ENSRNOP00065015022; ENSRNOG00065012051. [P62804-1]
DR   Ensembl; ENSRNOT00065039049; ENSRNOP00065031707; ENSRNOG00065022859. [P62804-1]
DR   Ensembl; ENSRNOT00065039088; ENSRNOP00065031743; ENSRNOG00065022881. [P62804-1]
DR   Ensembl; ENSRNOT00065039131; ENSRNOP00065031785; ENSRNOG00065022907. [P62804-1]
DR   Ensembl; ENSRNOT00065039256; ENSRNOP00065031889; ENSRNOG00065022983. [P62804-1]
DR   Ensembl; ENSRNOT00065039296; ENSRNOP00065031926; ENSRNOG00065023002. [P62804-1]
DR   Ensembl; ENSRNOT00065056230; ENSRNOP00065046328; ENSRNOG00065032701. [P62804-1]
DR   GeneID; 291152; -.
DR   GeneID; 295277; -.
DR   GeneID; 64627; -.
DR   KEGG; rno:291152; -.
DR   KEGG; rno:295277; -.
DR   KEGG; rno:64627; -.
DR   UCSC; RGD:620814; rat. [P62804-1]
DR   AGR; RGD:1304905; -.
DR   AGR; RGD:1306905; -.
DR   AGR; RGD:1307448; -.
DR   AGR; RGD:152995531; -.
DR   AGR; RGD:620814; -.
DR   CTD; 291152; -.
DR   CTD; 64627; -.
DR   CTD; 8370; -.
DR   RGD; 620814; Hist1h4b.
DR   eggNOG; KOG3467; Eukaryota.
DR   GeneTree; ENSGT01060000248528; -.
DR   HOGENOM; CLU_109117_2_3_1; -.
DR   InParanoid; P62804; -.
DR   OMA; RRNRNMS; -.
DR   OrthoDB; 5318557at2759; -.
DR   PhylomeDB; P62804; -.
DR   Reactome; R-RNO-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-RNO-110331; Cleavage of the damaged purine.
DR   Reactome; R-RNO-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-RNO-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-RNO-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-RNO-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-RNO-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-RNO-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-RNO-3214842; HDMs demethylate histones.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   Reactome; R-RNO-3214858; RMTs methylate histone arginines.
DR   Reactome; R-RNO-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-RNO-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-RNO-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-RNO-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-RNO-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-RNO-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-RNO-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-RNO-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-RNO-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-RNO-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-RNO-68616; Assembly of the ORC complex at the origin of replication.
DR   Reactome; R-RNO-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-RNO-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-RNO-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-RNO-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-RNO-9843940; Regulation of endogenous retroelements by KRAB-ZFP proteins.
DR   Reactome; R-RNO-9843970; Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex.
DR   PRO; PR:P62804; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000032224; Expressed in pancreas and 15 other cell types or tissues.
DR   GO; GO:0043505; C:CENP-A containing nucleosome; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0030527; F:structural constituent of chromatin; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045653; P:negative regulation of megakaryocyte differentiation; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISO:RGD.
DR   GO; GO:0001503; P:ossification; IEA:UniProtKB-KW.
DR   CDD; cd00076; H4; 1.
DR   Gene3D; 1.10.20.10; Histone, subunit A; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd_Histone-like_dom.
DR   PANTHER; PTHR10484; HISTONE H4; 1.
DR   PANTHER; PTHR10484:SF0; HISTONE H4; 1.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; Histone-fold; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Chromosome; Citrullination;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   DNA-binding; Hydroxylation; Isopeptide bond; Methylation; Nucleosome core;
KW   Nucleus; Osteogenesis; Phosphoprotein; Reference proteome; Secreted;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:5171427"
FT   CHAIN           2..103
FT                   /note="Histone H4"
FT                   /id="PRO_0000158355"
FT   PEPTIDE         90..103
FT                   /note="Osteogenic growth peptide"
FT                   /id="PRO_0000225591"
FT   DNA_BIND        17..21
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:5171427"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         4
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         4
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5 and PRMT7;
FT                   alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-acetyl-N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         6
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         9
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         13
FT                   /note="N6-acetyl-N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         13
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         17
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:5171427"
FT   MOD_RES         17
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         17
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         17
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         21
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         21
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:5171427"
FT   MOD_RES         21
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:5171427"
FT   MOD_RES         32
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         32
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         45
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         45
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         45
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         52
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         60
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         60
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         78
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         80
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         80
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         89
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         92
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   MOD_RES         92
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        13
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in UFM1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        80
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62805"
FT   VAR_SEQ         1..84
FT                   /note="Missing (in isoform OGP precursor)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018804"
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
